Anxiety, Cancer, Chemotherapy, Treatment Compliance, Virtual Reality
Conditions
Brief summary
The study was planned as a randomized controlled study to evaluate the effect of virtual reality glasses used on anxiety and treatment compliance in outpatient cancer patients receiving chemotherapy. The sample of the study consisted of a total of 30 patients, including 15 experimental and 15 control groups, who received intravenous chemotherapy treatment every 21 days between April 1 and September 31, 2023, in the outpatient chemotherapy unit of a research hospital. Research data will be collected using the Patient Information Form, Beck Anxiety Scale (BAI) and Chronic Disease Adaptation Scale (CCDS). In evaluating the data, it was planned to analyze the differences between the rates of categorical variables in independent groups with Chi-Square tests. It was planned to use t tests to compare quantitative continuous data between two independent groups. Dependent groups t-test will be used to compare measurements within groups. After being informed about the research, patients in both groups will be given a pre-test. Patients in the experimental group will be shown 3 different videos with virtual reality glasses during 3 cycles of chemotherapy treatment, and a final test will be administered to both groups at the end of the 3rd cycle..
Interventions
DEVICEWeight: 414g Size: 19.5cm x 14cm x 11cm Compatibility: Android and iOS VR Box 3.0 3D Virtual Reality Glasses Has the Feature of Fixation with Headband It has a lens mechanism tha
Patients in the experimental group were fitted with virtual reality glasses for 3 cycles and were allowed to watch videos of city tours, walks in the forest, and nature walks for 15 minutes, depending on their choice.
Sponsors
Gozde Oz
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
42 Years to 62 Years
Healthy volunteers
No
Inclusion criteria
* Being over 18 years old * Knowing Turkish, agreeing to participate in the research * Being diagnosed with cancer, regardless of the type of cancer * Starting an intravenous chemotherapy treatment regimen after diagnosis * Those who receive their treatment in 21-day periods to ensure equality in application frequencies. * Able to use virtual reality glasses * People without hearing or visual impairment are included
Exclusion criteria
* Anyone with any visual or hearing impairment * The patient does not know the diagnosis of cancer, has been diagnosed with cancer but has not received treatment or has completed the cure. * Those with brain tumor or brain metastasis are not included.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Virtual Reality Glasses | 3 month | Virtual Reality Glasses Used in Cancer Patients Will Reduce Anxiety Score on the Visual Analogue Scale in 3 Months |
Contacts
Primary ContactGÖZDE ÖZ
Outcome results
None listed